1203 related articles for article (PubMed ID: 18983377)
1. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P
Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma.
Cheng SH; Tsai SY; Yen KL; Jian JJ; Feng AC; Chan KY; Hong CF; Chu NM; Lin YC; Lin CY; Tan TD; Hsieh CY; Chong V; Huang AT
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):456-65. PubMed ID: 15667967
[TBL] [Abstract][Full Text] [Related]
4. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate.
Chu ST; Wu PH; Chou P; Lee CC
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S115-20. PubMed ID: 18236065
[TBL] [Abstract][Full Text] [Related]
5. Prevertebral muscle involvement in nasopharyngeal carcinoma.
Feng AC; Wu MC; Tsai SY; Chan KY; Cheng SH; Wang A; Chen SS; Jian JJ; Terng SD; Huang AT
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1026-35. PubMed ID: 16682150
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and outcome for nasopharyngeal carcinoma.
Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
[TBL] [Abstract][Full Text] [Related]
7. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
8. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].
Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J
Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881
[TBL] [Abstract][Full Text] [Related]
9. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract][Full Text] [Related]
11. Prognostic influence of parapharyngeal extension in nasopharyngeal carcinoma.
Ho HC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Lee CC; Chou P
Acta Otolaryngol; 2008 Jul; 128(7):790-8. PubMed ID: 18568523
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
Chua DT; Nicholls JM; Sham JS; Au GK
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
17. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
19. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.
Lin JC; Jan JS; Hsu CY; Jiang RS; Wang WY
Br J Cancer; 2003 Jan; 88(2):187-94. PubMed ID: 12610501
[TBL] [Abstract][Full Text] [Related]
20. Bidimensional measurement of nasopharyngeal carcinoma: a simple method to predict outcomes.
Lee CC; Ho HC; Su YC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Chou P; Lee CC
Clin Otolaryngol; 2009 Feb; 34(1):26-33. PubMed ID: 19260882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]